116 related articles for article (PubMed ID: 1003425)
1. Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.
Standridge RT; Howell HG; Gylys JA; Partyka RA; Shulgin AT
J Med Chem; 1976 Dec; 19(12):1400-4. PubMed ID: 1003425
[No Abstract] [Full Text] [Related]
2. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
Jacob JN; Nichols DE
J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
[TBL] [Abstract][Full Text] [Related]
3. Monomethylthio analogues of 1-(2,4,5-trimethoxyphenyl)-2-aminopropane.
Jacob P; Anderson G; Meshul CK; Shulgin AT; Castagnoli N
J Med Chem; 1977 Oct; 20(10):1235-9. PubMed ID: 903913
[TBL] [Abstract][Full Text] [Related]
4. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
[No Abstract] [Full Text] [Related]
5. Comparison of the effects of R-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM), r-(-)-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) and 5-hydroxytryptamine on non-innervated vascular smooth muscle.
Dyer DC
Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):449-54. PubMed ID: 959651
[TBL] [Abstract][Full Text] [Related]
6. Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) with R-DOM and S-amphetamine.
Tilson HA; Chamberlain JH; Gylys JA
Psychopharmacology (Berl); 1977 Jan; 51(2):169-73. PubMed ID: 402669
[TBL] [Abstract][Full Text] [Related]
7. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
Nichols DE; Barfknecht CF; Long JP; Standridge RT; Howell HG; Partyka RA; Dyer DC
J Med Chem; 1974 Feb; 17(2):161-6. PubMed ID: 4809251
[No Abstract] [Full Text] [Related]
8. The effect of chirality on serotonin receptor affinity.
Glennon RA
Life Sci; 1979 Apr; 24(16):1487-92. PubMed ID: 470548
[No Abstract] [Full Text] [Related]
9. Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.
Nichols DE; Woodard R; Hathaway BA; Lowy MT; Yom KW
J Med Chem; 1979 Apr; 22(4):458-60. PubMed ID: 430485
[TBL] [Abstract][Full Text] [Related]
10. Potent agonist activity of DOB at 5-HT2 receptors in guinea pig trachea.
Heller WA; Baraban JM
Eur J Pharmacol; 1987 Jun; 138(1):115-7. PubMed ID: 3622603
[TBL] [Abstract][Full Text] [Related]
11. Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes.
Standridge RT; Howell HG; Tilson HA; Chamberlain JH; Holava HM; Gylys JA; Partyka RA; Shulgin AT
J Med Chem; 1980 Feb; 23(2):154-62. PubMed ID: 7359529
[TBL] [Abstract][Full Text] [Related]
12. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
13. Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.
Oberlender RA; Kothari PJ; Nichols DE; Zabik JE
J Med Chem; 1984 Jun; 27(6):788-92. PubMed ID: 6737421
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines.
Dyer DC; Nichols DE; Rusterholz DB; Barfknecht CF
Life Sci; 1973 Oct; 13(7):885-96. PubMed ID: 4766265
[No Abstract] [Full Text] [Related]
15. Effect of 2,5-dimethoxy-4-methylamphetamine on heart and smooth muscle contraction.
Huang JT; Ho BT
J Pharm Pharmacol; 1974 Jan; 26(1):69-70. PubMed ID: 4150941
[No Abstract] [Full Text] [Related]
16. Further studies on BL-3912A: effects on avoidance behavior of rats with low baselines and on reaction thresholds to electric footshock.
Tilson HA; Chamberlain JH; Gylys JA
Pharmacol Biochem Behav; 1977 Jun; 6(6):627-30. PubMed ID: 263545
[TBL] [Abstract][Full Text] [Related]
17. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
Cheng HC; Long JP; Nichols DE; Barfknecht CF
J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
[No Abstract] [Full Text] [Related]
18. [3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.
Titeler M; Herrick K; Lyon RA; McKenney JD; Glennon RA
Eur J Pharmacol; 1985 Oct; 117(1):145-6. PubMed ID: 4085543
[No Abstract] [Full Text] [Related]
19. Structure-activity relationships in psychotomimetic phenylalkylamines.
Aldous FA; Barrass BC; Brewster K; Buxton DA; Green DM; Pinder RM; Rich P; Skeels M; Tutt KJ
J Med Chem; 1974 Oct; 17(10):1100-11. PubMed ID: 4418757
[No Abstract] [Full Text] [Related]
20. Serotonergic and dopaminergic involvement in the mechanism of action of R-(-)-2,5-dimethoxy-4-bromoamphetamine (DOB) in cats.
Rusterholz DB; Spratt JL; Long JP; Kelly TF
Life Sci; 1978 Oct; 23(14):1499-506. PubMed ID: 713706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
